Cargando…
Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: a case report
INTRODUCTION: The optimum management of a capillary haemangioblastoma affecting the optic nerve head is not clear. A number of treatment modalities have been used to treat the tumours and their consequences. Ocular haemangioblastomas express high levels of vascular endothelial growth factor and leve...
Autores principales: | de Klerk, Timothy A, Steel, David HW |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430573/ https://www.ncbi.nlm.nih.gov/pubmed/18510737 http://dx.doi.org/10.1186/1752-1947-2-182 |
Ejemplares similares
-
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Retinal haemangioblastomas in von Hippel–Lindau germline mutation carriers: progression, complications and treatment outcome
por: Hajjaj, Anass, et al.
Publicado: (2020) -
Supratentorial dural-based haemangioblastoma in a Native American patient without Von Hippel Lindau Syndrome
por: Kaloostian, PE, et al.
Publicado: (2012) -
Supratentorial haemangioblastoma without von Hippel–Lindau syndrome in an adult: A rare tumor with review of literature
por: Pandey, Sharad, et al.
Publicado: (2016) -
Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas
por: Hrisomalos, Frank N, et al.
Publicado: (2010)